HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,238,373,000 | +7.4% | 16,728 | -5.5% | 0.01% | 0.0% |
| Q2 2022 | $1,153,294,000 | +58922.2% | 17,694 | +14.2% | 0.01% | -44.4% |
| Q3 2019 | $1,954,000 | -50.6% | 15,493 | -52.9% | 0.02% | -50.0% |
| Q2 2019 | $3,959,000 | -16.0% | 32,897 | -39.0% | 0.04% | -14.3% |
| Q1 2019 | $4,715,000 | -14.4% | 53,901 | -2.1% | 0.04% | -14.3% |
| Q4 2018 | $5,510,000 | -68.9% | 55,070 | -64.4% | 0.05% | -49.5% |
| Q3 2018 | $17,732,000 | +96.0% | 154,755 | +53.4% | 0.10% | +106.4% |
| Q2 2018 | $9,045,000 | – | 100,859 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |